Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It targets both the GLP-1 receptor and the GIP receptor, which is glucose-dependent insulinotropic polypeptide
You gain some, you lose some and sometimes you plateau
Common Application Mistakes to Avoid Knowing where to place GLP-1 patches is only half the battle
Three-entity separation: Omzo's published materials describe the separation of platform, clinical provider, and pharmacy
Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Xultophy Patients nave to basal insulin or a GLP-1 agonist: starting dose is 10 units once daily Patients currently on basal insulin or a GLP-1 agonist: starting dose is 16 units once daily Maintenance: titrate dose up or down by 2 units once or twice weekly, depending on blood sugar goals Missed doses: resume dosing at the next scheduled dose
US$ 27.78
US$ 23.74
US$ 24.24
